Immunic Inc (NASDAQ:IMUX) Chief Scientific Officer Hella Kohlhof sheds light on her crucial role and the groundbreaking strides being made in the scientific world ahead of the International Day of Women and Girls in Science on 11 February.
As CSO, Kohlhof is pivotal in crafting the scientific strategy for Immunic's projects, focusing on understanding molecular actions, ensuring safety in preclinical regulatory work, and developing biomarkers for early activity indications. Her responsibilities extend beyond internal operations to engaging with stakeholders, including investors and scientists, highlighting the collaborative essence of scientific progress.
Kohlhof told Proactive her passion for science was ignited in her school days, fascinated by the intricate mechanisms of viruses. This curiosity led her from working as a lab technician to pursuing advanced studies in biology, culminating in a PhD focused on viral behavior. Her journey wasn't without challenges; she recalls a noteworthy incident underscoring the gender biases in science, which taught her the importance of resilience and not taking gendered assumptions personally.
For young women aspiring to careers in science, Kohlhof emphasizes the power of curiosity and the willingness to seize opportunities, even in the face of uncertainty. She advocates for a fearless approach to learning and exploration, underscoring that achievements in science come from a blend of passion and perseverance.